(株)DNAチップ研究所の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | サービス業 | 2397/E05389 | DNA Chip Research Inc. |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2022/11/11 | 日証協 | 120,100株 | -2.91% | 2,400株 | -73.91% | 476,620株 | -0.69% | 3,100株 | -76.69% |
2022/11/04 | 日証協 | 123,700株 | -2.52% | 9,200株 | +124.39% | 479,920株 | +1.18% | 13,300株 | +1107.99% |
2022/10/28 | 日証協 | 126,900株 | -2.76% | 4,100株 | -58.16% | 474,320株 | -1.19% | 1,101株 | -85.12% |
2022/10/21 | 日証協 | 130,500株 | -1.21% | 9,800株 | -13.27% | 480,019株 | +0.78% | 7,400株 | -47.52% |
2022/10/14 | 日証協 | 132,100株 | +0.15% | 11,300株 | +391.3% | 476,319株 | +0.02% | 14,100株 | +486.77% |
2022/10/07 | 日証協 | 131,900株 | -2.66% | 2,300株 | -95.56% | 476,219株 | +17% | 2,403株 | -90.19% |
2022/09/30 | 日証協 | 135,500株 | -1.74% | 51,800株 | +342.74% | 407,016株 | -14.73% | 24,500株 | +315.25% |
2022/09/22 | 日証協 | 137,900株 | +9.01% | 11,700株 | +1.74% | 477,319株 | +1.92% | 5,900株 | -60.14% |
2022/09/16 | 日証協 | 126,500株 | +2.43% | 11,500株 | -46.51% | 468,319株 | +0.11% | 14,800株 | -16.85% |
2022/09/09 | 日証協 | 123,500株 | +2.32% | 21,500株 | -40.28% | 467,819株 | +1.94% | 17,800株 | -53.89% |
2022/09/02 | 日証協 | 120,700株 | -5.92% | 36,000株 | +1340% | 458,919株 | -1.1% | 38,600株 | +1186.67% |
2022/08/26 | 日証協 | 128,300株 | -4.25% | 2,500株 | -79.84% | 464,019株 | +0.13% | 3,000株 | -70.59% |
2022/08/19 | 日証協 | 134,000株 | +2.21% | 12,400株 | +244.44% | 463,419株 | +0.32% | 10,200株 | +183.33% |
2022/08/12 | 日証協 | 131,100株 | -1.21% | 3,600株 | +33.33% | 461,919株 | -0.17% | 3,600株 | +200% |
2022/08/05 | 日証協 | 132,700株 | -0.15% | 2,700株 | -3.57% | 462,719株 | +0.11% | 1,200株 | -67.57% |
2022/07/29 | 日証協 | 132,900株 | -3.97% | 2,800株 | -70.83% | 462,219株 | -0.34% | 3,700株 | -7.5% |
2022/07/22 | 日証協 | 138,400株 | -0.14% | 9,600株 | +146.15% | 463,819株 | +0.06% | 4,000株 | -38.46% |
2022/07/15 | 日証協 | 138,600株 | -10.47% | 3,900株 | -72.34% | 463,519株 | -1.21% | 6,500株 | +30% |
2022/07/08 | 日証協 | 154,800株 | +0.19% | 14,100株 | -13.5% | 469,219株 | +0.9% | 5,000株 | -70.59% |
※株式分割は考慮していませんのでご注意ください。
Page Top